Recommendations to the NIH Spring 2020
|
Define clinical and genetic phenotypes across life course |
Expand genetic and epigenetic profiling beyond Chr21 |
Gather more unbiased -Omics data |
Develop and support better DS models (cells, rodents, non-human primate) |
Increase interdisciplinary/translational collaborations |
Expand support for drug and devise RCT’s across lifespan |
Increase life-style studies and interventions including physical fitness, health, and behavior |
Develop and disseminate methodology for cognitive/ behavior outcome measures for large, multi-site trials |
Expand clinical trial data sharing |
Expand support for centralized biorepositories and a single network for DS data across the life span |
Support training in clinical research/treatment for DS |
Expand inclusion of individuals with DS who have been under-represented and excluded from clinical studies |